Join the Levonorgestrel group to help and get support from people like you.
Levonorgestrel News
FDA Approval of Over-the-Counter Emergency Contraception Has Slashed ER Visits
TUESDAY, Jan. 30, 2024 – U.S. approval of over-the-counter emergency contraception like “Plan B” has had an unintended but positive side effect for America’s hospitals, a new study shows. Emergency r...
'Morning After' Pill Sales Surge on Day After New Years' Eve
THURSDAY, Dec. 21, 2023 — Even Valentine's Day apparently doesn't trump the start of a brand new year when it comes to getting frisky. Sales of the morning-after pill surged across the U.S. after New ...
Adverse Mental Health Symptoms Reported During Contraceptive Pill Pause
FRIDAY, Sept. 29, 2023 – For women taking combined oral contraceptives (COCs), withdrawal during the pill pause is associated with adverse mental health symptoms, similar to those experienced during...
Oral Piroxicam Plus Levonorgestrel Increases Efficacy of Emergency Contraception
THURSDAY, Aug. 17, 2023 – Oral piroxicam coadministered with levonorgestrel improves the efficacy of emergency contraception (EC), according to a study published online Aug. 16 in The Lancet....
FDA Approves Medicines360’s Supplemental New Drug Application for Liletta (levonorgestrel-releasing intrauterine system) 52 mg as Treatment of Heavy Menstrual Bleeding
SAN FRANCISCO, CA – July 10, 2023 – Medicines360, a global nonprofit organization with a mission to catalyze equitable access to quality medicines for women, announced today that the U.S. Food and...
FDA Approves Medicines360’s Liletta (levonorgestrel-releasing intrauterine system) 52 mg to Prevent Pregnancy for up to Eight Years
SAN FRANCISCO – Nov. 14, 2022 – Medicines360, a global nonprofit organization with a mission to expand women’s access to quality medicines, announced today that the U.S. Food and Drug Administration ...
FDA Approves Extension of Mirena (levonorgestrel-releasing intrauterine system) Intrauterine Device (IUD) for up to Eight Years of Pregnancy Prevention
WHIPPANY, N.J.--(BUSINESS WIRE)--Bayer, a leader in women's healthcare, announced today that the U.S. Food and Drug Administration (FDA) approved a supplemental new drug application (sNDA) that...
FDA Medwatch Alert: Voluntary Recall of Certain Family Dollar Over-the-Counter Products
July 21, 2022 – Family Dollar is initiating a voluntary retail level product recall of certain products regulated by the U.S. Food and Drug Administration (FDA) that were stored and inadvertently...
FDA Approves Liletta (levonorgestrel-releasing intrauterine system) to Prevent Pregnancy for up to Six Years
SAN FRANCISCO and DUBLIN October 28, 2019 – Medicines360, a global nonprofit organization with a mission to expand women’s access to quality medicines, and Allergan plc (NYSE: AGN), a leading global p...
FDA Approves Liletta (levonorgestrel-releasing intrauterine system) to Prevent Pregnancy for up to Five Years
DUBLIN and SAN FRANCISCO October 16, 2018 – Allergan plc (NYSE: AGN), a leading global pharmaceutical company, and Medicines360, a global nonprofit women’s health pharmaceutical company with a mis...
FDA Approves Liletta (levonorgestrel-releasing intrauterine system) to Prevent Pregnancy for up to Four Years
August 6, 2017 – Allergan plc (NYSE:AGN), a leading global pharmaceutical company, and Medicines360, a global nonprofit women's health pharmaceutical company with a mission of expanding access to...
FDA Approves Bayer's Kyleena (Levonorgestrel-Releasing Intrauterine System) for Prevention of Pregnancy for up to Five Years
WHIPPANY, N.J., Sept. 19, 2016 /PRNewswire/ – Bayer announced today that the U.S. Food and Drug Administration (FDA) approved Kyleena (levonorgestrel-releasing intrauterine system) 19.5 mg, a...
FDA Approves Liletta (levonorgestrel-releasing intrauterine system) to Prevent Pregnancy for up to Three Years
DUBLIN and SAN FRANCISCO, Feb. 27, 2015 /PRNewswire/ – Actavis plc (NYSE: ACT), a leading global specialty pharmaceutical company, and Medicines360, a nonprofit women's health pharmaceutical...
FDA Approves Plan B One-Step Emergency Contraceptive For Use Without A Prescription For All Women Of Child-Bearing Potential
June 20, 2013 – Today, the U.S. Food and Drug Administration announced it has approved the use of Plan B One-Step (levonorgestrel) as a nonprescription product for all women of child-bearing...
FDA Approves Plan B One-Step Emergency Contraceptive Without a Prescription for Women 15 Years of Age and Older
April 30, 2013 – The U.S. Food and Drug Administration today announced that it has approved an amended application submitted by Teva Women’s Health, Inc. to market Plan B One-Step (active ingredient ...
Ask a question
To post your own question to this support group, sign in or create an account.
Further information
Related condition support groups
Contraception, Birth Control, Emergency Contraception, Postcoital Contraception
Related drug support groups
Plan B One-Step, Mirena, Aftera, Kyleena